Thinking of joining a study?

Register your interest

NCT06877572 | RECRUITING | Endometrial Cancer Survivors


Weight Loss Management in Endometrial Cancer Survivors
Sponsor:

University of Kansas Medical Center

Information provided by (Responsible Party):

Melissa and

Brief Summary:

This study is being done to understand how oncologists can engage a multidisciplinary team to help endometrial cancer survivors with obesity to engage in a weight management program and potentially start a weight loss medication. Obesity often impacts the future health and longevity of early-stage endometrial cancer survivors more than their cancer diagnosis. Patients will be referred to the KUMC OB/Gyn weight management clinic to discuss weight management options. * If patients decide to use medications for weight loss, then the study will collect data from their chart that is recorded as part of routine monitoring for patients on weight loss medications. * If patients decide not to use any medications, the study will monitor physical exam and lab data collected as part of their routine medical care. The study will also try to understand reasons why patients did or did not start using a weight loss medication.

Condition or disease

Endometrial Cancer Survivors

Weight Management

Early Stage Endometrial Cancer

Intervention/treatment

Weight loss with pharmacotherapy

Weight loss without pharmacotherapy

Study Type : OBSERVATIONAL
Estimated Enrollment : 50 participants
Official Title : Enacting Active Survivorship: Implementation of Weight Management Strategies in Endometrial Cancer Survivors
Actual Study Start Date : 2025-03-25
Estimated Primary Completion Date : 2028-10
Estimated Study Completion Date : 2030-10

Information not available for Arms and Intervention/treatment

Ages Eligible for Study: 18 Years
Sexes Eligible for Study: FEMALE
Accepts Healthy Volunteers:
Criteria
Inclusion Criteria
  • * ≥18 years old
  • * ECOG 0-2
  • * BMI ≥ 30kg/m2
  • * Completed surgical staging with no evidence of residual disease
  • * Endometrioid endometrial adenocarcinoma, p53 wild type
  • * Stage 1
  • * Undergoing active surveillance +/- brachytherapy
Exclusion Criteria
  • * Unable to participate in behavior weight loss
  • * Stroke, heart attack, end stage liver disease, or end stage kidney disease during the last 6 months.
  • * Currently on a GLP-1 agonist
  • * Currently on insulin

Weight Loss Management in Endometrial Cancer Survivors

Location Details

NCT06877572


Please Choose a site



How to Participate

Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.

Locations


RECRUITING

United States, Kansas

University of Kansas Medical Center

Kansas City, Kansas, United States, 66160

Loading...